PTC Therapeutics, Inc. (NASDAQ:PTCT - Get Free Report) insider Neil Gregory Almstead sold 8,130 shares of the company's stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $85.26, for a total value of $693,163.80. Following the sale, the insider directly owned 60,137 shares of the company's stock, valued at approximately $5,127,280.62. This represents a 11.91% decrease in their ownership of the …